Nuclear factor κB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse

Journal of Neurochemistry

Volumn 87, Issue 4, 2003, Pages 1024-1036

  Nadjar, Agnès ^a   Combe, Chantal ^a   Layé, Sophie ^a   Tridon, Viviane ^a   Dantzer, Robert ^a   Amédée, Thierry ^a   Parnet, Patricia ^a,b  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b INSERM   (France)

Author keywords

Brain; Cytokine receptors; Interleukin 1 beta; Neuroimmunology; Nuclear factor B

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; SYNAPTOTAGMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL NUCLEUS; CELL TYPE; CONTROLLED STUDY; EMBRYO; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RAT; RNA SYNTHESIS;

ANIMALIA;

EID: 0344393076     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02097.x     Document Type: Article

References (40)

1. Almawi W. Y. and Melemedjian O. K. (2002) Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J. Mol. Endocrinol. 28, 69-78.
2. Anforth H. R., Bluthe R. M., Bristow A. et al. (1998) Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur. Cytokine Netw. 9, 279-288.
3. Auphan N., DiDonato J. A., Rosette C., Helmberg A. and Karin M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290.
4. Baeuerle P. A. and Henkel T. (1994) Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
5. Beg A. A. and Baldwin A. S. Jr (1993) The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7, 2064-2070.
6. Besedovsky H. O., del Rey A., Klusman I., Furukawa H., Monge Arditi G. and Kabiersch A. (1991) Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40, 613-618.
7. Bluthe R. M., Laye S., Michaud B., Combe C., Dantzer R. and Parnet P. (2000) Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur. J. Neurosci. 12, 4447-4456.
8. Cremona S., Goujon E., Kelley K. W., Dantzer R. and Parnet P. (1998) Brain type I but not type II IL-1 receptors mediate the effects of IL-1 beta on behavior in mice. Am. J. Physiol. 274, R735-R740.
9. Dantzer R. (2001a) Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15, 7-24.
10. Dantzer R. (2001b) Cytokine-induced sickness behavior: mechanisms and implications. Ann. N Y Acad. Sci. 933, 222-234.
11. Ericsson A., Liu C., Hart R. P. and Sawchenko P. E. (1995) Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361, 681-698.
12. Farmer P. and Pugin J. (2000) beta-adrenergic agonists exert their 'antiinflammatory' effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J Physiol. Lung Cell. Mol. Physiol. 279, L675-L682.
13. Fitzgerald K. A. and O'Neill L. A. (2000) The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence. Microbes Infect. 2, 933-943.
14. Gautron L., Lafon P., Chaigniau M., Tramu G. and Laye S. (2002) Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 112, 717-729.
15. Gavrilyuk V., Dello Russo C., Heneka M. T., Pelligrino D., Weinberg G. and Feinstein D. L. (2002) Norepinephrine 'increases I kappa B alpha expression in astrocytes. J. Biol. Chem. 277, 29662-29668.
16. Glaccum M. B., Stocking K. L., Charrier K., Smith J. L., Willis C. R., Maliszewski C., Livingston D. J., Peschon J. J. and Morrissey P. J. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159, 3364-3371.
17. Herkenham M., Lee H. Y. and Baker R. A. (1998) Temporal and spatial patterns of c-fos mRNA induced by intravenous interteukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 400, 175-196.
18. Kabiersch A., del Rey A., Honegger C. G. and Besedovsky H. O. (1988) Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2, 267-274.
19. Konsman J. P., Tridon V. and Dantzer R. (2000a) Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 101, 957-967.
20. Konsman J. P., Rees G., Ek M., Dantzer R., Ericsson-Dahlstrand A. and Blomqvist A. (2000b) Distribution of interleukin-1 receptor type 1 mRNA and protein in rat brain. Soc. Neurosci. Abstr. 26, 242.241.
21. Konsman J. P., Parnet P. and Dantzer R. (2002) Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25, 154-159.
22. Laflamme N. and Rivest S. (1999) Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J. Neurochem. 73, 309-321.
23. Lawrence T., Gilroy D. W., Colville-Nash P. R. and Willoughby D. A. (2001) Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7, 1291-1297.
24. Laye S., Parnet P., Goujon E. and Dantzer R. (1994) Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27, 157-162.
25. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R. and Parnet P. (2000) Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R93-R98.
26. Mercier F., Kitasako J. T. and Hatton G. I. (2003) Fractones and other basal laminae in the hypothalamus. J. Comp. Neurol. 455, 324-340.
27. Milligan C. E., Cunningham T. J. and Levitt P. (1991) Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain. J. Comp. Neurol. 314, 125-135.
28. Miyamoto S. and Verma I. M. (1995) Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66, 255-292.
29. Moynagh P. N., Williams D. C. and O'Neill L. A. (1994) Activation of NF-kappa B and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1. Modulation by antioxidants. J. Immunol. 153, 2681-2690.
30. Pahl H. L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
31. Parnet P., Pousset F. and Laye S. (2003) NF kappa B activation in mouse pituitary: comparison of response to interleukin-1 beta and lipopolysaccharide. J. Neuroendocrinol. 15, 304-314.
32. Proescholdt M. G., Chakravarty S., Foster J. A., Foti S. B., Briley E. M. and Herkenham M. (2002) Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience 112, 731-749.
33. Quan N., Whiteside M., Kim L. and Herkenham M. (1997) Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc. Natl Acad. Sci. USA 94, 10985-10990.
34. Quan N., He L., Lai W., Shen T. and Herkenham M. (2000) Induction of IkappaBalpha mRNA expression in the brain by glucocorticoids: a negative feedback mechanism for immune-to-brain signaling. J. Neurosci. 20, 6473-6477.
35. Scheinman R. I., Gualberto A., Jewell C. M., Cidlowski J. A. and Baldwin A. S. Jr (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953.
36. Shu S. Y., Ju G. and Fan L. Z. (1988) The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85, 169-171.
37. Swanson L. W. (1998) Brain Maps: Structure of the Rat Brain, 2nd edn. Elsevier, Amsterdam.
38. Traenckner E. B., Pahl H. L., Henkel T., Schmidt K. N., Wilk S. and Baeuerle P. A. (1995) Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14, 2876-2883.
39. Van Dam A. M., De Vries H. E., Kuiper J., Zijlstra F. J., De Boer A. G., Tilders F. J. and Berkenbosch F. (1996) Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? FASEB J. 10, 351-356.
40. Whiteside S. T., Epinat J. C., Rice N. R. and Israel A. (1997) I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16, 1413-1426.